SUBJECT INDEX 



605 



Ribonuclease 



bacteriophage and, 414 



influenza virus and, 11 



protein synthesis and, 95-96 



tobacco mosaic virus and, 414 



transesterification, ribonucleic acid bio- 

 synthesis and, 186-187 

 Ribonucleic acid, 1, 19 



base compositions 

 rat liver and, 99 



biosjaithesis of, 186-189 



cellular detection of, 35 



infective, UV inactivation and, 376 



influenza A virus and, 5 



influenza B virus and, 5 



influenza virus and, 11 



template and, 197-201 



tobacco mosaic virus, 6 



infectivity assay of, 437-439, 441- 



445 

 lability and, 448-450 

 miscellaneous reactions and, 450 

 molecular weight and, 446-448 



tomato bushy stunt virus and, 6 



turnip yellow mosaic virus and, 6 

 Ribonucleic acid synthesis 



enucleate cells and, 101 



incorporation data and, 99-101 



nuclear transfer and, 101 



polynucleotide phosphorylase and, 

 187-189 



protein synthesis dissociation from, 

 101-103 



ribonuclease transesterification and, 

 186-187 

 Rift Valley fever virus, plaque-count 



assay of, 336 

 Rous sarcoma virus, 53 



assay of, 332 



infection initiation and, 346 



local lesion count assay of, 335 



UV inactivation and, 375 



Saccharomyces, ploidy-dependent char- 

 acters in, 41, 42 



Safranine 



bacteriophage inactivation and, 418 

 tobacco mosaic virus inactivation and, 

 418 



Scaliylic acid, viral inactivation by, 407 



Salmonella 



cell wall composition, bacteriophage 

 genome control and, 556 



transduction in, 558 

 Salmonella typhimvrium, 129 



genie linear order in, 134 



P22 phage, radioactive phosphorus 

 decay in, 381 



synchronous culture, polymer synthesis 

 and, 107, 108 

 Sarcosomes, Drosophila and, 57 

 Scavenging reactions, nucleic acid inter- 

 mediate biosynthesis and, 176-177 

 SchifT reaction, polysaccharides and, 34 

 Sedimentation 



equilibrium, ultra centrifugation and, 

 265-266 



multicomponent, ultracentrifugation 

 and, 263-264 



partition cell, ultracentrifugation and, 

 264-265 



virus concentration determination, 

 electron microscopy and, 339-340 



virus identification and, 301-303 

 Sedimentation coefiicient, ultracentri- 

 fugation and, 255-257 

 Sequential induction, carbon compound 



degradation and, 140 

 Serological character, phenotypic mixing 



of, 11 

 Shope papilloma virus, 344 



infection initiation and, 348 

 Sialic acid, see Acetylneuraminic acid 

 Sickle cell anemia, mutant hemoglobin 



in, 134 

 Silkworm, see Bonibyx rnori 

 Silver, tobacco mosaic virus inactivation, 



and, 417 

 Simultaneous adaptation, see Sequential 



induction 

 Sodium deoxycholate 



arthropod-borne virus inactivation 

 and, 418 



influenza A virus inactivation and, 418 



lymphocytic choriomeningitis virus 

 inactivation and, 418 



polio viruses and, 418 

 Sodium dodecyl sulfate 



tobacco mosaic virus, nucleic acid 

 preparation and, 434 



